Scientific and technological advances are making it easier than ever for life sciences companies to expand clinical trial candidate bases, so, in many cases, they should be able to more accurately reflect their real-world patient population. Learn 5 key considerations for assessing and restructuring clinical trial design and processes to achieve better representation of target populations.
By Vijaya Prajwala, Liisa M. Eisenlohr, and Enno Behrendt.
This byline originally appeared in Applied Clinical Trials Online.
Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.